Flagship Products & Product Pipeline
Our Flagship Products
More products are developed, formulated and ready for further research and clinical trials.
ARTHRITIS
PSORIASIS
VIRUS & BACTERIA
- Reduces pain and the feeling of stiffness causes cooling effect, and improves mobility
- Quality assured and tested in compliance with MDD and in the process of updating according to MDR.
- Proven efficacy via preclinical study and ongoing clinical trial
- Patent-pending – classified as a Medical Device
- Reduces itchiness, redness, and dryness causes cooling effect, and hydrates the skin
- Quality assured and tested in compliance with MDD and in the process of updating according to MDR.
- Proven efficacy via preclinical study and ongoing clinical trial
- Patent-pending – classified as a Medical Device
- Helps to protect against bacteria and viruses
- Pharmaceutical manufacturer
- Dermatologically tested
- Application tested
ARTHRITIS
- Reduces pain and the feeling of stiffness causes cooling effect, and improves mobility
- Quality assured and tested in compliance with MDD and in the process of updating according to MDR.
- Proven efficacy via preclinical study and ongoing clinical trial
- Patent-pending – classified as a Medical Device
PSORIASIS
- Reduces itchiness, redness, and dryness causes cooling effect, and hydrates the skin
- Quality assured and tested in compliance with MDD and in the process of updating according to MDR.
- Proven efficacy via preclinical study and ongoing clinical trial
- Patent-pending – classified as a Medical Device
VIRUS & BACTERIA
- Helps to protect against bacteria and viruses
- Pharmaceutical manufacturer
- Dermatologically tested
- Application tested
CannaSen Product Pipeline is Deep and Robust
Our product pipeline is focused on therapeutic areas where we believe we have the best opportunity to deliver high quality treatment and care with the use of cannabinoids.
Certifications & Guidelines
Certificates and guidelines our subcontractors comply with and/or have obtained.
Certifikat och riktlinjer som våra underleverantörer följer och/eller har erhållit.
